Clinical trial
ZD1839 With Hypofractionated Radiation Therapy With an Immobilization Device for…
NCT00328562 · Sidney Kimmel Cancer Center at Thomas Jefferson University, Other · Completed
Key facts
| NCT number | NCT00328562 |
|---|---|
| Title | ZD1839 With Hypofractionated Radiation Therapy With an Immobilization Device for Advanced Non-Small Cell Lung Cancer |
| Official title | A Phase I Study of ZD1839 (Iressa) and Hypofractionated Thoracic Radiotherapy With Stereotactic Body Frame Immobilization for Patients With Advanced Non-Small Cell Lung Cancer |
| Lead sponsor | Sidney Kimmel Cancer Center at Thomas Jefferson University, Other |
| Collaborators | AstraZeneca Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Non-Small Cell Lung Carcinoma (NSCLC) |
| Intervention type | Drug, Radiation |
| Interventions | ZD1839 (Iressa), Thoracic Radiotherapy |
| Enrollment | 13 |
| Start date | Dec 1, 2003 |
| Primary completion | Apr 1, 2008 |
| Completion | Sep 1, 2010 |
| First posted | May 22, 2006 |
| Last update posted | May 4, 2025 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: